AEG35156 and Docetaxel in Treating Patients With Solid Tumors
Status:
Completed
Trial end date:
2010-06-07
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing.
AEG35156 may help docetaxel work better by making tumor cells more sensitive to the drug.
PURPOSE: This phase I trial is studying the side effects and best dose of AEG35156 when given
together with docetaxel in treating patients with solid tumors.